drugset / Trial / NCT05957471
Study of BC3195 Monotherapy in Patients With Advanced Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
This is a phase I study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC3195 in Patients with Locally Advanced or Metastatic Solid Tumors.
Timeline
- Start
- 2023-06-26
- Primary completion
- 2025-06
- Completion
- 2025-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BC3195 | Unknown | — | Intravenous |
Indications
No indication recorded.